Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.
作者信息
Miyazaki Motoyasu, Takata Tohru, Yoshimura Hisae, Matsunaga Akira, Ohta Daiki, Ishikura Hiroyasu, Futo Maki, Hara Shuji, Kamimura Hidetoshi, Tamura Kazuo, Ngo Dung, Tsuji Brian T
出版信息
Antimicrob Agents Chemother. 2011 Apr;55(4):1819-20. doi: 10.1128/AAC.01536-10. Epub 2011 Jan 31.
Abstract
摘要
相似文献
1
Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.万古霉素杀菌活性作为耐甲氧西林金黄色葡萄球菌菌血症患者30天死亡率的预测指标
Antimicrob Agents Chemother. 2011 Apr;55(4):1819-20. doi: 10.1128/AAC.01536-10. Epub 2011 Jan 31.
2
Bacterial factors influencing the mortality for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.影响耐甲氧西林金黄色葡萄球菌（MRSA）菌血症死亡率的细菌因素。
Infect Dis (Lond). 2016 Aug;48(8):649-50. doi: 10.1080/23744235.2016.1180710. Epub 2016 May 11.
3
Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.耐甲氧西林金黄色葡萄球菌菌血症在血液透析和非血液透析患者中的表现。
J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.
4
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.耐甲氧西林金黄色葡萄球菌引起的菌血症：新治疗方法的最新进展。
Infect Dis Clin North Am. 2020 Dec;34(4):849-861. doi: 10.1016/j.idc.2020.04.003. Epub 2020 Sep 30.
5
Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.万古霉素最低抑菌浓度对侵袭性金黄色葡萄球菌感染治疗结果的影响
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01845-16. Print 2017 Mar.
6
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.在一项针对耐甲氧西林金黄色葡萄球菌血流感染的倾向性匹配分析中，无论万古霉素最低抑菌浓度如何，达托霉素均可改善治疗结果。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct.
7
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.高万古霉素最低抑菌浓度是耐甲氧西林金黄色葡萄球菌菌血症患者死亡的预测因素。
Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.
8
Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.血培养分离出的万古霉素最低抑菌浓度为 2μg/ml 的耐甲氧西林金黄色葡萄球菌菌株的临床特征。
J Infect Chemother. 2011 Feb;17(1):52-7. doi: 10.1007/s10156-010-0086-0. Epub 2010 Jul 13.
9
[Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].[耐甲氧西林金黄色葡萄球菌菌血症的评估及根据万古霉素最低抑菌浓度值比较预后：过去十年的经验]
Mikrobiyol Bul. 2013 Apr;47(2):199-210. doi: 10.5578/mb.4530.
10
Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.新生小鼠耐甲氧西林金黄色葡萄球菌的治疗：溶葡萄球菌酶与万古霉素的对比
Pediatr Res. 2009 Apr;65(4):420-4. doi: 10.1203/PDR.0b013e3181994a53.
引用本文的文献
1
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance.临床分离株中的抗生素耐受性：机制、检测、流行情况及意义。
Clin Microbiol Rev. 2024 Dec 10;37(4):e0010624. doi: 10.1128/cmr.00106-24. Epub 2024 Oct 4.
2
Targeted Therapy of Severe Infections Caused by in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence.危重症成年患者由[具体病原体未给出]引起的严重感染的靶向治疗：基于真实世界证据的治疗算法多学科建议。
Microorganisms. 2023 Feb 3;11(2):394. doi: 10.3390/microorganisms11020394.
3
Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia.耐甲氧西林金黄色葡萄球菌菌血症的死亡率与分子流行病学之间的关系。
PLoS One. 2022 Jul 8;17(7):e0271115. doi: 10.1371/journal.pone.0271115. eCollection 2022.
4
Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.药师干预在治疗耐甲氧西林金黄色葡萄球菌菌血症患者万古霉素治疗中的作用。
PLoS One. 2018 Sep 6;13(9):e0203453. doi: 10.1371/journal.pone.0203453. eCollection 2018.
5
Rapid and easy detection of low-level resistance to vancomycin in methicillin-resistant Staphylococcus aureus by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.基质辅助激光解吸电离飞行时间质谱法快速简便检测耐甲氧西林金黄色葡萄球菌低水平万古霉素耐药性。
PLoS One. 2018 Mar 9;13(3):e0194212. doi: 10.1371/journal.pone.0194212. eCollection 2018.
6
Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌中万古霉素缓慢生长非敏感性的流行情况。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00452-17. Print 2017 Nov.
7
Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Survive in Kupffer Cells and Exhibit High Virulence in Mice.形成生物膜的耐甲氧西林金黄色葡萄球菌在库普弗细胞中存活并在小鼠中表现出高毒力。
Toxins (Basel). 2016 Jun 30;8(7):198. doi: 10.3390/toxins8070198.
8
Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.万古霉素24小时曲线下面积与最低杀菌浓度比值作为耐甲氧西林金黄色葡萄球菌菌血症死亡率的新型预测指标。
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3070-5. doi: 10.1128/AAC.02714-15. Print 2016 May.
9
Activated ClpP kills persisters and eradicates a chronic biofilm infection.激活的 ClpP 可杀死持续存在的细菌并根除慢性生物膜感染。
Nature. 2013 Nov 21;503(7476):365-70. doi: 10.1038/nature12790. Epub 2013 Nov 13.
10
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌引起的持续性或复发性血流感染中，具有降低糖肽类药物敏感性的分离株的高发生率。
Antimicrob Agents Chemother. 2012 Mar;56(3):1258-64. doi: 10.1128/AAC.05808-11. Epub 2011 Dec 12.
本文引用的文献
1
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.万古霉素最低抑菌浓度（MIC）与接受万古霉素治疗的耐甲氧西林金黄色葡萄球菌血症患者治疗失败之间的关系。
Antimicrob Agents Chemother. 2008 Sep;52(9):3315-20. doi: 10.1128/AAC.00113-08. Epub 2008 Jun 30.
2
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.万古霉素最低抑菌浓度对耐甲氧西林金黄色葡萄球菌菌血症治疗的影响
Clin Infect Dis. 2008 Jan 15;46(2):193-200. doi: 10.1086/524667.
3
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.万古霉素的体外杀菌活性及其与清除耐甲氧西林金黄色葡萄球菌菌血症疗效的关系。
Antimicrob Agents Chemother. 2007 Jul;51(7):2582-6. doi: 10.1128/AAC.00939-06. Epub 2007 Apr 23.
4
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.耐甲氧西林金黄色葡萄球菌在万古霉素治疗下的适应性变化
Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S40-50. doi: 10.1086/491713.
5
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.耐甲氧西林金黄色葡萄球菌中辅助基因调节子II型多态性可预测万古霉素治疗失败。
Clin Infect Dis. 2004 Jun 15;38(12):1700-5. doi: 10.1086/421092. Epub 2004 May 21.
6
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.万古霉素治疗耐甲氧西林金黄色葡萄球菌菌血症时的最低抑菌浓度（MIC）和杀菌活性与疗效的关系。
J Clin Microbiol. 2004 Jun;42(6):2398-402. doi: 10.1128/JCM.42.6.2398-2402.2004.
7
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.金黄色葡萄球菌菌血症：一项前瞻性多中心研究中的复发情况及抗生素治疗的影响
Medicine (Baltimore). 2003 Sep;82(5):333-9. doi: 10.1097/01.md.0000091184.93122.09.
Zotero 插件